S.2192: A bill to establish a user fee for follow-up reinspections under the Federal Food, Drug, and Cosmetic Act.

About This Bill

Bill Summary

Directs the Secretary of Health and Human Services to collect a user fee from each manufacturer of a food, drug, device, biological product, or animal drug for which a followup reinspection is required to ensure correction of a violation of a Good Manufacturing Practices requirement under the Federal Food, Drug, and Cosmetic Act found by the Secretary during the initial inspection of the manufacturer.

(Source: Library of Congress)

Bill Actions

Date Description
Sponsor introductory remarks on measure.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Oct. 18, 2007

Introduced in the Senate by Russ Feingold (D-Wis.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page